Trials / Withdrawn
WithdrawnNCT04741048
Hearing Implant Performance in Adults With Low-Frequency Residual Hearing
A Pre-market, Open-label Feasibility, Prospective, Single-arm Multicenter Feasibility Investigation of Hearing Performance Using the CI624 in Adults With Low-frequency Residual Hearing.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Cochlear · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI624 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CI624 Slim 20 Electrode | Cochlear Ltd CI624 cochlear implant with Slim 20 Electrode |
Timeline
- Start date
- 2021-03-08
- Primary completion
- 2023-04-01
- Completion
- 2023-04-01
- First posted
- 2021-02-05
- Last updated
- 2021-10-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04741048. Inclusion in this directory is not an endorsement.